Filtros : "ADENOSINA" "DIABETES MELLITUS" Removidos: "ALIMENTAÇÃO" "FM-MPT" "Anais" Limpar

Filtros



Refine with date range


  • Source: New england journal of medicine. Unidade: FM

    Subjects: CORONARIOPATIA, DIABETES MELLITUS, ADENOSINA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      STEG, P. Gabriel et al. Ticagrelor in patients with stable coronary disease and diabetes. New england journal of medicine, v. 381, n. 14, p. 1309-1320, 2019Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1908077. Acesso em: 01 out. 2024.
    • APA

      Steg, P. G., Bhatt, D. L., Simon, T., Fox, K., Mehta, S. R., Harrington, R. A., et al. (2019). Ticagrelor in patients with stable coronary disease and diabetes. New england journal of medicine, 381( 14), 1309-1320. doi:10.1056/NEJMoa1908077
    • NLM

      Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Nicolau JC. Ticagrelor in patients with stable coronary disease and diabetes [Internet]. New england journal of medicine. 2019 ; 381( 14): 1309-1320.[citado 2024 out. 01 ] Available from: https://doi.org/10.1056/NEJMoa1908077
    • Vancouver

      Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Nicolau JC. Ticagrelor in patients with stable coronary disease and diabetes [Internet]. New england journal of medicine. 2019 ; 381( 14): 1309-1320.[citado 2024 out. 01 ] Available from: https://doi.org/10.1056/NEJMoa1908077
  • Source: British Journal of Pharmacology. Unidade: FMRP

    Subjects: ENDOTÉLIO VASCULAR, ADENOSINA, HIPERTENSÃO, DIABETES MELLITUS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MATSUMOTO, Takayuki et al. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. British Journal of Pharmacology, v. 172, n. 16, p. 3980-4001, 2015Tradução . . Disponível em: https://doi.org/10.1111/bph.13205. Acesso em: 01 out. 2024.
    • APA

      Matsumoto, T., Goulopoulou, S., Taguchi, K., Tostes, R. de C. A., & Kobayashi, T. (2015). Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. British Journal of Pharmacology, 172( 16), 3980-4001. doi:10.1111/bph.13205
    • NLM

      Matsumoto T, Goulopoulou S, Taguchi K, Tostes R de CA, Kobayashi T. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes [Internet]. British Journal of Pharmacology. 2015 ; 172( 16): 3980-4001.[citado 2024 out. 01 ] Available from: https://doi.org/10.1111/bph.13205
    • Vancouver

      Matsumoto T, Goulopoulou S, Taguchi K, Tostes R de CA, Kobayashi T. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes [Internet]. British Journal of Pharmacology. 2015 ; 172( 16): 3980-4001.[citado 2024 out. 01 ] Available from: https://doi.org/10.1111/bph.13205

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024